Frentzas, S., Morris, M. F., Barnet, M. B., Tebbutt, N. C., Wong, M., Michael, M., Kim, H., Lee, K., Rha, S. Y., Oh, S. C., Wu, I., Bai, L., Chou, W., Chen, M., Chen, Y., Lin, C., Ptacek, J., Alonso, M. N., Arshad, T., Lim, S. (2026). A phase 1/2 study of BDC-4182, a Claudin 18.2–targeting next-generation immune-stimulating antibody conjugate (ISAC), in patients with advanced gastric and gastroesophageal cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps4242